2752

Morningstar's Pat Dorsey gets drug-industry insight and 5-star stock ideas from analyst Damien Conover.

...Merck ...GlaxoSmithKline Plc has a rival product called Cervarix waiting in the wings, which is slightly behind in development. Cervarix was filed for approval in Europe in March and Glaxo aims to ...

CNBC interviews Jean-Pierre Garnier, chief of pharmaceutical giant GlaxoSmithKline, on the company's earnings decline from generic competition.

...pharmaceutical ...workers the management skills. While he agrees that these are all relevant issues, Kim really wants an integrated response. He’d like to see medical schools like Harvard, where ...

Jean-Pierre Garnier, chief executive officer of GlaxoSmithKline Plc, talks with Bloomberg's Deborah Kostroun from New York about the company's drug development, investment in research and development,...